glp 1 agonist example Glucagon-like peptide-1 GLP-1 Agonists are commonly used
Description
Risk of pancreatic adverse events associated with the use of glucagon-like peptide-1 receptor agonist and dipeptidyl peptidase-4 inhibitor drugs: a systematic review and meta-analysis of randomized trials
These side effects typically lessen over time
131,225 GLP-1s action on -cells regulates glucagon release
Jankowski, J., Floege, J., Fliser, D., Bohm, M
